Axsome Therapeutics Inc (AXSM)
87.15
-1.69
(-1.90%)
USD |
NASDAQ |
Nov 04, 16:00
87.16
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Profit Margin (Quarterly): -91.03% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -91.03% |
| March 31, 2024 | -91.14% |
| December 31, 2023 | -137.9% |
| September 30, 2023 | -107.6% |
| June 30, 2023 | -143.8% |
| Date | Value |
|---|---|
| March 31, 2023 | -11.86% |
| December 31, 2022 | -251.3% |
| September 30, 2022 | -266.1% |
| June 30, 2022 | -469.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-469.8%
Minimum
Jun 2022
-11.86%
Maximum
Mar 2023
-174.5%
Average
-137.9%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Krystal Biotech Inc | 22.15% |
| Pfizer Inc | 25.22% |
| Sarepta Therapeutics Inc | 1.78% |
| Moderna Inc | -578.7% |
| NovaBay Pharmaceuticals Inc | -66.04% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -156.4% |
| Return on Assets | -53.30% |
| Return on Invested Capital | -82.21% |
| Gross Profit Margin (Quarterly) | 90.76% |
| Operating Margin (Quarterly) | -87.06% |
| Return on Net Operating Assets | -172.9% |